1994•Clinical Drug InvestigationRequires access

A Clinical and Economic Comparison of ft Roxithromycin 150mg Twice Daily vs Amoxicillin 500mg/Clavulanic Acid 125mg Three Times Daily for the Treatment of Lower Respiratory Tract Infections in General Practice

Noel Karalus, J. E. Garrett, S. D. R. Lang, W. G. Scott, R. A. Leng, G. N. Kostalas, Ray Cursons, B. C. Cooper, Helen Scott

Open publisher page 7 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Roxithromycin, Amoxicillin, Clavulanic acid, Medicine, Amoxicillin/clavulanic acid, Regimen, Lower respiratory tract infection, Internal medicine

Back to paper search Browse research topics Original source

A Clinical and Economic Comparison of ft Roxithromycin 150mg Twice Daily vs Amoxicillin 500mg/Clavulanic Acid 125mg Three Times Daily for the Treatment of Lower Respiratory Tract Infections in General Practice — Research Paper | ScholarLens